Our Mission
MAIVAN is all about unlocking the power of healthcare AI through clinical validation and adoption.
At MAIVAN, we are committed to advancing the field of orthopedics through innovative artificial intelligence solutions. Our mission is to enhance the precision, efficiency, and outcomes of orthopedic care by leveraging cutting-edge AI technologies.
Application of artificial intelligence technology in the field of orthopedics: a narrative review. Liu, P., Zhang, J., Liu, S. et al. Artif Intell Rev 57, 13 (2024)
Our Structure
To ensure the highest standards of integrity, compliance, and innovation, MAIVAN operates through two distinct legal entities:
1. MAIVAN AI Conformity Assessment Body (a Swiss Verein)
Role: The MAIVAN Verein non-profit Swiss Association – hosted by University of Basel’s Department of Biomedical Engineering – is dedicated to conducting and coordinating validation studies and conformity assessments for AI systems in orthopedics at the MAIVAN network’s hospital and research centres – as a presumptive Conformity Assessment Body (CAB) under the EU AI Act. It ensures that orthopedic AI solutions meet the stringent safety, performance, and ethical standards required by the EU AI Act, the FDA, and other relevant regulations and authorities.
Founding Members: We are proud that leading orthopedic associations, such as EFORT (European Federation of National Associations of Orthopaedics and Traumatology) and AOSSM (American Orthopaedic Society for Sports Medicine), have expressed interest in collaborating with the MAIVAN CAB Verein. Their involvement underscores our commitment to excellence and credibility in conformity assessments required by the EU AI Act, the FDA, and other relevant regulations and authorities.
2. MAIVAN.ai AG (a Public Benefit Corporation)
Role: The MAIVAN.ai AG commercial entity, headquartered in Zurich/Switzerland, focuses on developing, testing, validating, and deploying AI solutions for the medical industry, starting with orthopedics. It engages in business activities, including partnerships, sales, and consulting services.
Activities: Our team collaborates with hospitals, clinics, medical professionals, and the healthcare industry to integrate AI into clinical workflows, improving the diagnosis, treatment, and management of medical conditions.
The MAIVAN Association and Network interacts closely with and extends to parallel international initiatives for medical AI validation, such as the newly launched U.S.-based Coalition for Health AI (CHAI™) and its Quality Assurance Labs.
MAIVAN Collaboration – legal framework
The legal framework for collaboration between the two MAIVAN entities ensures that the non-profit entity can leverage the technical expertise and resources of the commercial entity without compromising its impartiality.
Our Team: Collaboration and Innovation
Our diverse team of experts brings together extensive experience in orthopedics, AI, data science, and regulatory compliance. We are passionate about driving innovation while adhering to the highest standards of safety and quality.
We believe in the power of collaboration to drive innovation. By partnering with leading orthopedic associations, research institutions, and healthcare providers, we continually refine our technologies to meet the evolving needs of the orthopedic community.
MAIVAN AG PBC provides a pioneering platform that combines an AI & Data Marketplace with AI Validation & Adoption Services, with a mission to revolutionize healthcare through clinically validated artificial intelligence (AI) solutions.
As a Public Benefit Corporation (PBC), MAIVAN AG operates at the forefront of AI innovation in the medical field, addressing the challenges of data scarcity and facilitating the deployment of AI technologies to improve patient outcomes and cost savings.
MAIVAN’s mission is to bridge the gap between AI innovation and clinical adoption in medicine. By leveraging advanced AI algorithms and a robust clinical validation framework, MAIVAN aims to transform medicine by providing healthcare providers with validated AI solutions for diagnostics, treatment planning, and surgical support. The company is committed to promoting ethical and responsible AI development while ensuring adherence to the highest clinical standards.
MAIVAN Key Pillars
Leveraging AI Foundation Models & Data Marketplace
MAIVAN offers a unique ecosystem for developing, testing, validating and deploying high-quality AI models and data for medicine.
Utilizing the power of Google Cloud and NVIDIA’s secure and scalable infrastructure, MAIVAN.ai hosts and deploys AI models for automated imaging analysis, fracture detection & classification, treatment recommendations, implant selection, and surgical planning. These models are designed to seamlessly integrate into existing healthcare systems, fostering widespread adoption and improving patient care efficiency.
The marketplace also addresses the data scarcity challenges that hinder AI development in the field. Through advanced fracture simulation algorithms, MAIVAN provides unlimited access to synthetic X-rays, CT scans, and MRI images, catering to various orthopedic conditions and fracture types. The data generation process is customizable based on specific requirements, such as fracture location, severity, and patient demographics. To ensure data integrity and secure licensing, MAIVAN integrates blockchain technology (NFTs) into its platform. Additionally, federated learning capabilities enable privacy-preserving collaborative AI development.
AI Validation and Deployment
MAIVAN offers a comprehensive platform for the clinical validation and deployment of AI solutions in orthopedic diagnostics, treatment planning, and surgical support. Leveraging strategic partnerships with the leading orthopedic & trauma associations, MAIVAN enables the “crowd-validation” of AI algorithms by a global network of over 100,000 orthopedic surgeons. This unique approach ensures that AI technologies meet the highest clinical standards while promoting responsible development. MAIVAN’s platform includes a curated AI marketplace for validated solutions, performance-based contracting models tied to measurable improvements in patient outcomes and cost savings, and seamless integration with healthcare providers’ existing systems and workflows.
Business Model
MAIVAN PBC’s business model revolves around Value-based Healthcare (VBHC) principles, aligning financial success with demonstrable improvements in patient outcomes and cost savings.
The company generates revenue through licensing its validated AI solutions and data. It offers flexible pricing models, including subscription-based licensing for access to the AI solutions and data marketplace, transaction-based commissions on AI solution sales and licensing, and performance-based contracts tied to measurable improvements in patient outcomes and cost savings.
Target Markets and Customers:
MAIVAN’s target markets encompass various stakeholders within the orthopedic healthcare ecosystem. These include:
Healthcare Providers: Hospitals, clinics, and medical centers specializing in orthopedics and trauma care, seeking to enhance diagnostic accuracy, optimize treatment pathways, and improve patient outcomes through validated AI solutions.
AI Solution Developers: Companies and research institutions developing AI algorithms for medical imaging analysis, fracture detection, predictive modeling, and surgical planning in the orthopedic domain.
Medical Device Manufacturers: Providers of imaging equipment, implants, and surgical instruments interested in integrating clinically validated AI solutions to enhance their product offerings.
Payers and Insurance Companies: Organizations focused on value-based healthcare models and interested in adopting cost-effective AI solutions that can improve treatment outcomes while reducing overall healthcare expenditures.
Competitive Advantage:
MAIVAN’s competitive advantage lies in its strategic partnerships with the leading orthopedic & trauma associations, which provide access to a global network of orthopedic surgeons and healthcare providers for the validation of AI solutions. This community-driven validation process ensures that MAIVAN’s AI technologies meet the highest clinical standards.
Furthermore, MAIVAN’s commitment to value-based healthcare principles and its focus on ethical and responsible AI development sets it apart from competitors. By offering flexible pricing models and integrating seamlessly with existing healthcare systems, MAIVAN aims to provide comprehensive and accessible solutions to its target markets.
Market Trends:
The healthcare AI market is rapidly evolving, with a growing focus on value-based healthcare models, data privacy and security, regulatory developments, and collaborative ecosystems. MAIVAN is well-positioned to capitalize on these trends by aligning its business model with value-based healthcare principles, implementing robust data security measures, and actively engaging with regulatory bodies. The company’s strategic partnerships and community-driven validation process enable it to stay ahead of market developments and maintain a competitive edge.
MAIVAN is at the forefront of revolutionizing orthopedic care through the integration of AI technologies. With a focus on ethical AI practices and adherence to the highest clinical standards, MAIVAN is committed to transforming orthopedic care and shaping the future of AI in the field. Through its unique networked business model, strategic partnerships, and commitment to value-based healthcare, MAIVAN is poised to make a significant impact in the orthopedic industry and pave the way for the widespread adoption of validated AI solutions.
MAIVAN.ai – Bringing AI to the Point of Care
